Prudential Financial’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Sell
62,433
-5,257
-8% -$155K ﹤0.01% 1363
2026
Q1
$1.88M Sell
67,690
-21,680
-24% -$557K ﹤0.01% 1335
2025
Q4
$1.94M Buy
89,370
+72,025
+415% +$1.42M ﹤0.01% 1329
2025
Q3
$262K Sell
17,345
-285
-2% -$3.53K ﹤0.01% 2138
2025
Q2
$199K Sell
17,630
-1,430
-8% -$15.5K ﹤0.01% 2213
2025
Q1
$192K Buy
19,060
+3,290
+21% +$35.6K ﹤0.01% 2082
2024
Q4
$187K Sell
15,770
-230
-1% -$2.72K ﹤0.01% 2101
2024
Q3
$185K Buy
16,000
+2,680
+20% +$30.5K ﹤0.01% 2523
2024
Q2
$141K Buy
13,320
+70
+0.5% +$767 ﹤0.01% 2524
2024
Q1
$140K Buy
+13,250
New +$143K ﹤0.01% 2501

Other funds holding ROIV

Prudential Financial's ROIV Position: Q2 2026 in Review

Prudential Financial reduced its Roivant Sciences (ROIV) stake by 7.8% in Q2 2026, selling an estimated $155K and leaving 62,433 shares worth $2.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1363.

Prudential Financial first reported a position in ROIV in Q1 2024 and has held it in 10 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Prudential Financial held 62,433 shares of Roivant Sciences worth $2.21M as of Q2 2026.
  • Prudential Financial sold 5,257 Roivant Sciences shares in Q2 2026, an estimated $155K.
  • Roivant Sciences made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1363 holding.
  • Prudential Financial first reported a position in Roivant Sciences in Q1 2024 and has held it in 10 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.